bupivacaine has been researched along with Diabetic Foot in 4 studies
Bupivacaine: A widely used local anesthetic agent.
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide : A piperidinecarboxamide obtained by formal condensation of the carboxy group of N-butylpipecolic acid with the amino group of 2,6-dimethylaniline.
bupivacaine : A racemate composed of equimolar amounts of dextrobupivacaine and levobupivacaine. Used (in the form of its hydrochloride hydrate) as a local anaesthetic.
Diabetic Foot: Common foot problems in persons with DIABETES MELLITUS, caused by any combination of factors such as DIABETIC NEUROPATHIES; PERIPHERAL VASCULAR DISEASES; and INFECTION. With the loss of sensation and poor circulation, injuries and infections often lead to severe foot ulceration, GANGRENE and AMPUTATION.
Excerpt | Relevance | Reference |
---|---|---|
"A case series of patients with diabetic nephropathy, who underwent lower limb debridement or amputation below the knee during successful combined sciatic and femoral nerve block with bupivacaine 0." | 5.36 | Femoral and sciatic nerve block with 0.25% bupivacaine for surgical management of diabetic foot syndrome: an anesthetic technique for high-risk patients with diabetic nephropathy. ( Arslan, G; Bozdogan, N; Caliskan, E; Eker, EH; Kocum, A; Turkoz, A, 2010) |
"Intrathecal midazolam acts synergically with other anesthetics to relieve surgical pain, and the drug combination may decrease complications attributable to each component drug." | 2.71 | Intrathecal midazolam combined with low-dose bupivacaine improves postoperative recovery in diabetic mellitus patients undergoing foot debridement. ( Hong, CC; Hung, CP; Lu, HF; Shiau, JM; Tseng, CC; Wu, YW, 2005) |
"Reducing and preventing postoperative pain are currently a topic of great interest." | 1.36 | Chronic, painful lower extremity wounds: postoperative pain management through the use of continuous infusion of regional anaesthesia supplied by a portable pump device. ( Armstrong, DG; Bharara, M; Fisher, TK; Scimeca, CL, 2010) |
"A case series of patients with diabetic nephropathy, who underwent lower limb debridement or amputation below the knee during successful combined sciatic and femoral nerve block with bupivacaine 0." | 1.36 | Femoral and sciatic nerve block with 0.25% bupivacaine for surgical management of diabetic foot syndrome: an anesthetic technique for high-risk patients with diabetic nephropathy. ( Arslan, G; Bozdogan, N; Caliskan, E; Eker, EH; Kocum, A; Turkoz, A, 2010) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Scimeca, CL | 1 |
Fisher, TK | 1 |
Bharara, M | 1 |
Armstrong, DG | 1 |
Kocum, A | 1 |
Turkoz, A | 1 |
Bozdogan, N | 1 |
Caliskan, E | 1 |
Eker, EH | 1 |
Arslan, G | 1 |
Sertoz, N | 1 |
Deniz, MN | 1 |
Ayanoglu, HO | 1 |
Wu, YW | 1 |
Shiau, JM | 1 |
Hong, CC | 1 |
Hung, CP | 1 |
Lu, HF | 1 |
Tseng, CC | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Comparison of Ultrasound-Guided Axillary Brachial Plexus Block Properties in Diabetic and Non-diabetic Patients: A Prospective Observational Study[NCT02685475] | 71 participants (Actual) | Observational | 2015-02-28 | Completed | |||
The Difference in Duration of Sciatic Nerve Block Between Diabetic and Non-diabetic Patients[NCT02482831] | 53 participants (Anticipated) | Observational | 2014-09-30 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for bupivacaine and Diabetic Foot
Article | Year |
---|---|
Intrathecal midazolam combined with low-dose bupivacaine improves postoperative recovery in diabetic mellitus patients undergoing foot debridement.
Topics: Aged; Anesthesia, Spinal; Bupivacaine; Debridement; Diabetic Foot; Humans; Injections, Spinal; Midaz | 2005 |
3 other studies available for bupivacaine and Diabetic Foot
Article | Year |
---|---|
Chronic, painful lower extremity wounds: postoperative pain management through the use of continuous infusion of regional anaesthesia supplied by a portable pump device.
Topics: Analgesics; Anesthesia, Local; Bupivacaine; Debridement; Diabetic Foot; Humans; Infusion Pumps; Male | 2010 |
Femoral and sciatic nerve block with 0.25% bupivacaine for surgical management of diabetic foot syndrome: an anesthetic technique for high-risk patients with diabetic nephropathy.
Topics: Aged; Aged, 80 and over; Anesthetics, Local; Bupivacaine; Diabetic Foot; Diabetic Nephropathies; Dos | 2010 |
Relationship between glycosylated hemoglobin level and sciatic nerve block performance in diabetic patients.
Topics: Aged; Anesthetics, Local; Bupivacaine; Diabetes Mellitus; Diabetic Foot; Glycated Hemoglobin; Humans | 2013 |
Relationship between glycosylated hemoglobin level and sciatic nerve block performance in diabetic patients.
Topics: Aged; Anesthetics, Local; Bupivacaine; Diabetes Mellitus; Diabetic Foot; Glycated Hemoglobin; Humans | 2013 |
Relationship between glycosylated hemoglobin level and sciatic nerve block performance in diabetic patients.
Topics: Aged; Anesthetics, Local; Bupivacaine; Diabetes Mellitus; Diabetic Foot; Glycated Hemoglobin; Humans | 2013 |
Relationship between glycosylated hemoglobin level and sciatic nerve block performance in diabetic patients.
Topics: Aged; Anesthetics, Local; Bupivacaine; Diabetes Mellitus; Diabetic Foot; Glycated Hemoglobin; Humans | 2013 |